Sudarshan Pharma Industries Limited IPO (Sudarshan Pharma IPO) Detail

Jun 12, 2019 - Jun 21, 2019

Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.

The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.

The competitive strengths of the company are:

1. Customer-centric and order driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing and sales network
5. Diversified business operations

Company Financials

Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
Total Assets 5,013.72 3,096.37 1,992.93 827.24
Total Revenue 14,001.96 8,976.43 5,551.72 3,794.33
Profit After Tax 234.79 73.98 15.63 9.27

Objects of the Issue

The Net Proceeds from the Issue are proposed to be utilized by the Company for the following objects:

1) To set up a dedicated manufacturing facility for Pharmaceutical Business;
2) Distribution and Warehousing Centre's & Purchase of Corporate Office;
3) Additional Working Capital;
4) General Corporate Expenses; and
5) To meet the expenses of the Issue.

Sudarshan Pharma IPO Details

Sudarshan Pharma IPO Date Jun 12, 2019 to Jun 21, 2019
Sudarshan Pharma IPO Face Value ₹10 per share
Sudarshan Pharma IPO Price ₹72 per share
Sudarshan Pharma IPO Lot Size 1600 Shares
Issue Size3,440,000 shares of ₹10
(aggregating up to ₹24.77 Cr)
Issue Type Fixed Price Issue IPO
Listing At NSE SME
Company Promoters

Mr. Hemal V. Mehta and Mr. Sachin V. Mehta are the promoters of the company.

Sudarshan Pharma IPO Timeline (Tentative Timetable)

Sudarshan Pharma IPO opens on Jun 12, 2019, and closes on Jun 21, 2019. The Sudarshan Pharma IPO bid date is from Jun 12, 2019 10.00 A.M. to Jun 21, 2019 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.

Event Date
Sudarshan Pharma IPO Opening Date Jun 12, 2019
Sudarshan Pharma IPO Closing Date Jun 21, 2019
Basis of Allotment Jun 20, 2019
Initiation of Refunds Jun 21, 2019
Credit of Shares to Demat Jun 24, 2019
Sudarshan Pharma IPO Listing Date Jun 25, 2019

Sudarshan Pharma IPO Lot Size

The Sudarshan Pharma IPO lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹115,200).

Application Lots Shares Amount
Retail (Min) 1 1600 ₹115,200
Retail (Max) 1 1600 ₹115,200

Sudarshan Pharma IPO Promoter Holding

Pre Issue Share Holding 89.29%
Post Issue Share Holding 65.63%

IPO Notices

External Link

Withdrawal of initial public offer by Sudarshan Pharma Industries Limited

Date: 24 June 2019

The Company has decided to withdraw the application made for SME IPO on NSE Platform due to material changes in the current business model and future expansion plan. The entire application money will be refunded forthwith.

Sudarshan Pharma IPO Review

Pharmaceutical industries are a highly regulated sector. Currently, pharma shares are not fancied by investors. Recent listings of SME Pharma companies have disappointed investors with the poor debut.  Considering aggressive pricing, there is no harm in giving this issue a miss.

Read detail review...

Sudarshan Pharma IPO Subscription Status (Bidding Detail)

The Sudarshan Pharma IPO is subscribed 0.47 times on Jun 21, 2019 6:00:01 PM. The public issue subscribed 0.77 times in the retail category, times in the QIB category, and 0.17 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Sudarshan Pharma IPO Prospectus

Sudarshan Pharma IPO Rating

Rating:Rated 3.6 stars
Vote Here ...

Company Contact Information

Sudarshan Pharma Industries Limited
301, 3rd Floor, Aura Biplex,
Above Kalyan Jewellers, S V Road,
Borivali (West), Mumbai - 400 092,
Phone: +91 22 242221111

Sudarshan Pharma IPO Registrar

KFin Technologies Limited

Phone: 04067162222, 04079611000

Sudarshan Pharma IPO Review

Sudarshan Pharma IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 0 0 1
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

IPO Broker Recommendations

Sudarshan Pharma IPO FAQs

Sudarshan Pharma IPO is a SME IPO of 3,440,000 equity shares of the face value of ₹10 aggregating up to ₹24.77 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600 Shares.

The IPO opens on Jun 12, 2019, and closes on Jun 21, 2019.

KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

The Sudarshan Pharma IPO opens on Jun 12, 2019 and closes on Jun 21, 2019.

Sudarshan Pharma IPO lot size is 1600 Shares and the minimum order quantity is .

You can apply in Sudarshan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Sudarshan Pharma IPO will be done on Jun 20, 2019, and the allotted shares will be credited to your demat account by Jun 24, 2019. Check the Sudarshan Pharma IPO allotment status.

The Sudarshan Pharma IPO listing date is not yet announced. The tentative date of Sudarshan Pharma IPO listing is Jun 25, 2019.
Open an Instant Account with Zerodha

Sudarshan Pharma IPO Message Board

Ranked Members of Forum  Ranked Members | Most Liked Members



40. MR. KUMAR |   Link |Jun 23, 2019 1:58:35 PM
Thumb rule of making more money in ipo is one and only subscriptions .If overall subscriptions is more than 20 times then 100 percent good listing gain happens whether company is good or bad. e.g - E2E NETWORK, MAHICKRA, DANGEE DUMS, D P ABHUSHAN .So if subscriptions is less then 20 times then there will be a big risk.
39. Satishsg |   Link |Jun 18, 2019 6:34:24 PM
Sudarshan Pharma is into the Forward Integration from chemical to Finished Formulation and the company is growing up so fast, also I had visited Sudarshan Pharma official website so I suggest to purchased IPO LOTS.
39.1. papon |   Link |Jun 20, 2019 10:27:55 AM
Top Contributor Top Contributor (400+ Posts, 400+ Likes)
Company has so much demand for their products but no demand for their shares. So ipo need to be extended. So sad
39.2. MR. KUMAR |   Link |Jun 22, 2019 12:58:09 PM
Who are you to suggested?? Are you a researcher???
38. Purvi Lakhani |   Link |Jun 18, 2019 6:56:32 PM
Sudarshan pharma is fastest growing company (as per profit and Revenue) hence I suggest to everyone for subscription of Sudarshan pharma IPO.
38.4. MR. KUMAR |   Link |Jun 20, 2019 11:25:11 AM
This is your first post , are you a company promoters???
38.5. Small Investor |   Link |Jun 21, 2019 11:09:57 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
# Purvi your Company IPO is Flop Show
37. Shivani dubey |   Link |Jun 21, 2019 7:36:07 AM
If everything seems under control, you are not going fast enough.... Let the people take their call.... Champions keep playing until they get it right..... If you can't say good,dont say bad...
36. Sunil Shivaji Murkute |   Link |Jun 18, 2019 5:38:44 PM
Company product are good and company customer base is strong, products drive is the company and customer loyalty key to success,so I have purchase few lots.
36.1. papon |   Link |Jun 20, 2019 10:16:21 AM
Top Contributor Top Contributor (400+ Posts, 400+ Likes)
Many company agents bids got rejected in earlier issues. Kindly check if your bid is ok or else you will not get allotment & you will be in depression
35. MR. KUMAR |   Link |Jun 19, 2019 3:55:27 PM
Avoid all sme and invest your money in mutual funds and get 20 percent return.
34. MR. KUMAR |   Link |Jun 19, 2019 3:53:38 PM
See the conditions of Par drugs.
33. MR. KUMAR |   Link |Jun 19, 2019 3:52:42 PM
Don't apply in Sudarshan pharma. It's fair price is RS 40 .So if you apply you will be in heavy loss.
32. Small Investor |   Link |Jun 19, 2019 10:54:55 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
There are Company's Agent coming to promote Company
keep away
31. Dilip Davda |   Link |Jun 17, 2019 8:21:50 PM
Due to heavy under subscription, Issue stands extended till 24th June 2019. Company has also reduced the price to Rs. 72 per share from Rs. 75 per share, still valuation is very much on the higher side. My conclusion remains the same despite price reduction. - Simply Avoid.

Dilip Davda
SEBI registered Research Analyst

Read my IPO Reviews

30. GrowYourMoney |   Link |Jun 17, 2019 5:01:50 PM
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
extended till 24th June
29. GrowYourMoney |   Link |Jun 17, 2019 3:52:29 PM
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
10 Mins to go (HNI Subscription)



seems extension or withdrawal on cards

28. GrowYourMoney |   Link |Jun 17, 2019 3:34:02 PM
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
some guys were very positive on this co

but it seems

they haven't invested

still under subscribed (HNI few min away)
27. KING VINOD |   Link |Jun 17, 2019 3:20:53 PM
IPO Guru IPO Guru (1700+ Posts, 3400+ Likes)
Clearly Avoid
26. Hiteshji |   Link |Jun 16, 2019 2:46:54 PM
IPO Mentor IPO Mentor (500+ Posts, 400+ Likes)
Completely avoid sme now days. Look for better company and batter valuations.
25. Aviralguptak |   Link |Jun 15, 2019 6:34:47 PM
They priced in 55 rs but later they changed to 75 rs.look at greed of merchant banker.lets skip it completely
At least other issue like Evans gk
Price at very low pe. They are pricing at even higher than its big company in main board. Shame
24. Aviralguptak |   Link |Jun 15, 2019 10:41:04 AM
First overseas last 15 issues almost 11 issues are down between 50 to 80 pc of issue price. Retailer please save your money. Please donate to orphanage rather than giving money to these lootera LM and such overvaluated asking greedy LM and companies. Request you to check the greed of the company and merchant banker asking for 40 pe. Please save unheard earn money and don't fall in their trap of a0plication applied and will be withdrawn on last day
24.1. Small Investor |   Link |Jun 15, 2019 11:38:41 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
Promoters rs 10 ka shares 75 m sell kr rha ,vese LM bhi kisi kam ka nhi h,mostly stock are trading in huge discount and few only above issue price jo risk leta ho wo isme Apply kr sakta h and but i do't risk i skip this
avoid avoid
23. Aviralguptak |   Link |Jun 15, 2019 8:48:35 AM
Please do not apply
There are Farzi bids made by company and its employee and relative which will be cancelled at last day
Please save your hard earn money. It has come up with very high price and first overseas its Im is anyway lootera. It priced first at 55 rs and then increased to 75. It does not deserve price of more than 40 rs
Coming up with 30 crore issue with 40 pe is anyway crime. Don't let these lootera take away your money
22. Aviralguptak |   Link |Jun 15, 2019 1:56:10 AM
Instead of applying in these companies let us all those in this group float a company and come with our own lpo sme. It is a guarantee money return which we all can share with no risk at all
This is what govt/exchange are doing giving hard earn money of innocent retailer to these companies. There should always been some control of exchange to get quality s rips only rather than anyone can come. Let us all join hands not to apply in any new issues. We should all come up with our own loo which is very easy nowdays
21. Sundaram Badholiya |   Link |Jun 14, 2019 3:21:09 AM
Wanna buy some shares.